CASI Pharmaceuticals
CASI
CASI
57 hedge funds and large institutions have $80.8M invested in CASI Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 3 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.43% more ownership
Funds ownership: 0.71% → 1.14% (+0.43%)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$19.2M | |
| 2 | +$4.69M | |
| 3 | +$4.05M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.86M |
| 5 |
WSC
Wellington Shields & Co
New York
|
+$2.68M |
Top Sellers
| 1 | -$3.39M | |
| 2 | -$1.08M | |
| 3 | -$743K | |
| 4 |
Barclays
London,
United Kingdom
|
-$349K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$232K |